Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Avorn

Showing results (111-120 of 436) with videos related to

Pageof 44
Sort By:
Lancet (London, England)|July 13, 2002
Non-steroidal anti-inflammatory drugs and risk of serious coronary heart diseaseDaniel H Solomon, Robert J Glynn, Jerry Avorn
Plos Medicine|June 2, 2011
Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic reviewKirsten E Austad, Jerry Avorn, Aaron S Kesselheim
Journal of General Internal Medicine|September 25, 2021
Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 PandemicBenjamin N Rome, Jerry Avorn, Aaron S Kesselheim
Health Affairs (Project Hope)|October 6, 2010
Designing comparative effectiveness research on prescription drugs: lessons from the clinical trial literatureDave A Chokshi, Jerry Avorn, Aaron S Kesselheim
The New England Journal of Medicine|January 23, 2023
Sources of Innovation in Gene Therapies - Approaches to Achieving Affordable PricesKerstin N Vokinger, Jerry Avorn, Aaron S Kesselheim
JAMA Network Open|January 25, 2023
Variation in Use of Lung Cancer Targeted Therapies Across State Medicaid Programs, 2020-2021Thomas J Roberts, Aaron S Kesselheim, Jerry Avorn
JAMA|February 7, 2013
FDA regulation of off-label drug promotion under attackAaron S Kesselheim, Michelle M Mello, Jerry Avorn
JAMA|January 15, 2020
FDA Approval and Regulation of Pharmaceuticals, 1983-2018Jonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
Journal of General Internal Medicine|November 3, 2020
Variations in Generic Combination Opioid Use Across State Medicaid ProgramsChangWon C Lee, Aaron S Kesselheim, Jerry Avorn
JAMA|July 12, 2022
Over-the-Counter Availability of Rescue Inhalers for Asthma-ReplyWilliam B Feldman, Jerry Avorn, Aaron S Kesselheim
Pageof 44

Showing results (111-120 of 436) with videos related to

Sort By:
Pageof 44
Lancet (London, England)|July 13, 2002
Non-steroidal anti-inflammatory drugs and risk of serious coronary heart diseaseDaniel H Solomon, Robert J Glynn, Jerry Avorn
Plos Medicine|June 2, 2011
Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic reviewKirsten E Austad, Jerry Avorn, Aaron S Kesselheim
Journal of General Internal Medicine|September 25, 2021
Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 PandemicBenjamin N Rome, Jerry Avorn, Aaron S Kesselheim
Health Affairs (Project Hope)|October 6, 2010
Designing comparative effectiveness research on prescription drugs: lessons from the clinical trial literatureDave A Chokshi, Jerry Avorn, Aaron S Kesselheim
The New England Journal of Medicine|January 23, 2023
Sources of Innovation in Gene Therapies - Approaches to Achieving Affordable PricesKerstin N Vokinger, Jerry Avorn, Aaron S Kesselheim
JAMA Network Open|January 25, 2023
Variation in Use of Lung Cancer Targeted Therapies Across State Medicaid Programs, 2020-2021Thomas J Roberts, Aaron S Kesselheim, Jerry Avorn
JAMA|February 7, 2013
FDA regulation of off-label drug promotion under attackAaron S Kesselheim, Michelle M Mello, Jerry Avorn
JAMA|January 15, 2020
FDA Approval and Regulation of Pharmaceuticals, 1983-2018Jonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
Journal of General Internal Medicine|November 3, 2020
Variations in Generic Combination Opioid Use Across State Medicaid ProgramsChangWon C Lee, Aaron S Kesselheim, Jerry Avorn
JAMA|July 12, 2022
Over-the-Counter Availability of Rescue Inhalers for Asthma-ReplyWilliam B Feldman, Jerry Avorn, Aaron S Kesselheim
Pageof 44